Key points are not available for this paper at this time.
The metallocene cation complex Cp*2ZrCH3(+)B(C6F5)4(-) inserts the phosphino-substituted alkyne Ph-C≡C-PPh2 into the Zr-CH3 bond to form the internally phosphane-stabilized cation Cp*2Zr-C(═CMePh)PPh2(+) (10). Complex 10 adds alkyl isocyanides as well as pivalonitrile at a lateral site at the bent metallocene wedge with retention of the Zr-P bond. Complex 10 acts as a reactive frustrated Lewis pair toward heterocumulenes, undergoing Zr(+)/P addition reactions to the carbonyl groups of an alkyl isocyanate and of carbon dioxide to form the respective five-membered metallaheterocyclic adducts 13 and 14. With mesityl azide complex 10 undergoes a Zr(+)/P FLP N,N-addition reaction at the terminal azide nitrogen atom to form the four-membered FLP cycloadduct 15. The Zr(+)/P FLP is a reactive hydrogen activator. In a stoichiometric reaction it generates a hydridozirconocene cation that subsequently serves as a hydrogenation catalyst for various olefinic or acetylenic substrates. The Zr(+)/P pair 10 undergoes selective 1,4-addition reactions to conjugated enones and to a conjugated ynone to give the corresponding seven-membered metallacyclic Zr(+)/P FLP addition products. Many compounds of this study were characterized by X-ray diffraction.
Xu et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: